MI Cancer Seek

Caris Life Sciences is a leading precision medicine and molecular diagnostics company focused on optimizing cancer care through comprehensive molecular profiling. The company's flagship offerings, including the MI Cancer Seek liquid biopsy and MI Profile tissue-based assays, utilize whole exome and whole transcriptome sequencing to provide clinicians with actionable insights for treatment selection. By integrating advanced artificial intelligence with one of the world's largest clinical-genomic datasets, Caris enables personalized therapeutic strategies and supports biopharmaceutical drug development. The company operates high-throughput, CLIA-certified laboratories and maintains extensive clinical trial matching services to accelerate the delivery of precision oncology.